Sphera Funds Management’s Inhibrx, Inc. Common Stock INBX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-226,551
Closed -$8.61M 126
2023
Q4
$8.61M Sell
226,551
-29,820
-12% -$639K 1.39% 24
2023
Q3
$4.7M Buy
256,371
+206,371
+413% +$4.32M 0.86% 42
2023
Q2
$1.3M Buy
+50,000
New +$1.17M 0.2% 81
2022
Q1
Sell
-61,931
Closed -$2.71M 106
2021
Q4
$2.71M Sell
61,931
-248,146
-80% -$9.92M 0.3% 69
2021
Q3
$10.3M Buy
310,077
+120,994
+64% +$3.68M 0.87% 37
2021
Q2
$5.2M Buy
189,083
+74,440
+65% +$1.55M 0.35% 76
2021
Q1
$2.3M Buy
114,643
+71,461
+165% +$2.09M 0.18% 106
2020
Q4
$1.42M Buy
+43,182
New +$1.15M 0.13% 92

Other funds holding INBX

Sphera Funds Management's INBX Position: Q1 2024 in Review

Sphera Funds Management sold out of Inhibrx, Inc. Common Stock (INBX) in Q1 2024, closing a stake of 226,551 shares — an estimated $8.61M sold.

Sphera Funds Management first reported a position in INBX in Q4 2020 and held it in 8 quarters. The position peaked at $10.3M in Q3 2021. 126 funds tracked by Wall St. Rank hold INBX as of Q1 2024.

  • Sphera Funds Management reported no remaining Inhibrx, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Sphera Funds Management sold 226,551 Inhibrx, Inc. Common Stock shares in Q1 2024, an estimated $8.61M.
  • Sphera Funds Management first reported a position in Inhibrx, Inc. Common Stock in Q4 2020 and held it in 8 quarters.
  • Sphera Funds Management's Inhibrx, Inc. Common Stock position peaked at $10.3M in Q3 2021.
  • 126 funds tracked by Wall St. Rank held Inhibrx, Inc. Common Stock as of Q1 2024.

Based on Sphera Funds Management's 13F filing for Q1 2024, filed 15 May 2024.